2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients

Adverse glycaemia in hospital is associated with worse clinical outcomes. Given the high prevalence of diabetes in the cardiology wards, we introduced an early intervention model of diabetes care in high-risk inpatients aiming to decrease adverse glycaemia. A prospective pre- and post-intervention s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2019-06, Vol.68 (Supplement_1)
Hauptverfasser: FOURLANOS, SPIROS, MINGOS, NICHOLAS D., ROWAN, LOIS M., BARMANRAY, RAHUL, KYI, MERVYN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Diabetes (New York, N.Y.)
container_volume 68
creator FOURLANOS, SPIROS
MINGOS, NICHOLAS D.
ROWAN, LOIS M.
BARMANRAY, RAHUL
KYI, MERVYN
description Adverse glycaemia in hospital is associated with worse clinical outcomes. Given the high prevalence of diabetes in the cardiology wards, we introduced an early intervention model of diabetes care in high-risk inpatients aiming to decrease adverse glycaemia. A prospective pre- and post-intervention study was conducted in a tertiary referral hospital cardiology ward. It consisted of an initial 6-month baseline phase of standard care (a ‘reactive’ referral-based diabetes consultation service), followed by an 9-month intervention phase, comprising a ‘proactive’ multidisciplinary inpatient diabetes team (IDT) assisted by networked blood glucose (BG) meter technology. The proactive IDT performed electronic surveillance of capillary BG measurements and provided an early consultation service (within 24 hours of admission), without waiting for referral from the parent team. Consecutive inpatients admitted to the cardiology ward (length of stay >48 hours) at high risk of adverse glycaemia (insulin treatment prior to hospital; or BG 15 or two BG >10 mmol/L in the first 48 hours) were recruited. BG data from day 2 until discharge, along with demographic and clinical features, was collected. The primary outcome was the incidence of adverse glycaemic days (AGD) (rate per 1000 patient-days with any capillary BG measure 15 mmol/L). Overall, we observed 332 patients (1320patient-days and 4887 BG measurements). Compared to usual care, the incidence of AGD decreased from 405 to 320 per 1000 patient-days (21% decrease, p=0.002) which remained significant after MVA adjustment. During the intervention phase, there was decreased mean (±SD) patient-day BG (10.8 ±3.3 vs. 10.1 ±2.8, p15 mmol/L) (10.4% vs. 6.1%, p=0.044) with no significant difference in patient-days with hypoglycaemia. Analysis of clinical outcomes is pending. An early intervention model of diabetes care decreased adverse glycaemia in cardiology in patients with diabetes.
doi_str_mv 10.2337/db19-2374-PUB
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2248398474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2248398474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c664-19734c0402109b059d09b30216d179eba7110c808c8e744b72c655fd647c8a43</originalsourceid><addsrcrecordid>eNo1kN1LwzAUxYMoWKePvhd8jt58tGl80zndYKD4Ab6FNE1n5mxm0gn9702Zch8OF36ce89B6JzAJWVMXDU1kZgywfHT2-0ByohkEjMq3g9RBkAoJkKKY3QS4xoAyjQZWvzz1_lMh82Q3zld297GfNH1NvzYrne-y1sf8rlbfeBnFz_zqQ6N8xu_GhK11b1LVDxFR63eRHv2pxP0cj97nc7x8vFhMb1ZYlOWHBMpGDfAgRKQNRSyScLSVjbpO1trQQiYCipTWcF5Lagpi6JtSi5MpTmboIu96zb4752NvVr7XejSQUUpr5isuBgpvKdM8DEG26ptcF86DIqAGrtSY1dqzK5SdvYLPOJZzQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2248398474</pqid></control><display><type>article</type><title>2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>FOURLANOS, SPIROS ; MINGOS, NICHOLAS D. ; ROWAN, LOIS M. ; BARMANRAY, RAHUL ; KYI, MERVYN</creator><creatorcontrib>FOURLANOS, SPIROS ; MINGOS, NICHOLAS D. ; ROWAN, LOIS M. ; BARMANRAY, RAHUL ; KYI, MERVYN</creatorcontrib><description>Adverse glycaemia in hospital is associated with worse clinical outcomes. Given the high prevalence of diabetes in the cardiology wards, we introduced an early intervention model of diabetes care in high-risk inpatients aiming to decrease adverse glycaemia. A prospective pre- and post-intervention study was conducted in a tertiary referral hospital cardiology ward. It consisted of an initial 6-month baseline phase of standard care (a ‘reactive’ referral-based diabetes consultation service), followed by an 9-month intervention phase, comprising a ‘proactive’ multidisciplinary inpatient diabetes team (IDT) assisted by networked blood glucose (BG) meter technology. The proactive IDT performed electronic surveillance of capillary BG measurements and provided an early consultation service (within 24 hours of admission), without waiting for referral from the parent team. Consecutive inpatients admitted to the cardiology ward (length of stay &gt;48 hours) at high risk of adverse glycaemia (insulin treatment prior to hospital; or BG &lt;4, &gt;15 or two BG &gt;10 mmol/L in the first 48 hours) were recruited. BG data from day 2 until discharge, along with demographic and clinical features, was collected. The primary outcome was the incidence of adverse glycaemic days (AGD) (rate per 1000 patient-days with any capillary BG measure &lt;4 or &gt;15 mmol/L). Overall, we observed 332 patients (1320patient-days and 4887 BG measurements). Compared to usual care, the incidence of AGD decreased from 405 to 320 per 1000 patient-days (21% decrease, p=0.002) which remained significant after MVA adjustment. During the intervention phase, there was decreased mean (±SD) patient-day BG (10.8 ±3.3 vs. 10.1 ±2.8, p&lt;0.001), decreased patient-days with hyperglycaemia (BG &gt;15 mmol/L) (10.4% vs. 6.1%, p=0.044) with no significant difference in patient-days with hypoglycaemia. Analysis of clinical outcomes is pending. An early intervention model of diabetes care decreased adverse glycaemia in cardiology in patients with diabetes.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db19-2374-PUB</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Blood glucose ; Cardiology ; Clinical outcomes ; Diabetes ; Diabetes mellitus ; Early intervention ; Hyperglycemia ; Hypoglycemia ; Insulin ; Patients</subject><ispartof>Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)</ispartof><rights>Copyright American Diabetes Association Jun 1, 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>FOURLANOS, SPIROS</creatorcontrib><creatorcontrib>MINGOS, NICHOLAS D.</creatorcontrib><creatorcontrib>ROWAN, LOIS M.</creatorcontrib><creatorcontrib>BARMANRAY, RAHUL</creatorcontrib><creatorcontrib>KYI, MERVYN</creatorcontrib><title>2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients</title><title>Diabetes (New York, N.Y.)</title><description>Adverse glycaemia in hospital is associated with worse clinical outcomes. Given the high prevalence of diabetes in the cardiology wards, we introduced an early intervention model of diabetes care in high-risk inpatients aiming to decrease adverse glycaemia. A prospective pre- and post-intervention study was conducted in a tertiary referral hospital cardiology ward. It consisted of an initial 6-month baseline phase of standard care (a ‘reactive’ referral-based diabetes consultation service), followed by an 9-month intervention phase, comprising a ‘proactive’ multidisciplinary inpatient diabetes team (IDT) assisted by networked blood glucose (BG) meter technology. The proactive IDT performed electronic surveillance of capillary BG measurements and provided an early consultation service (within 24 hours of admission), without waiting for referral from the parent team. Consecutive inpatients admitted to the cardiology ward (length of stay &gt;48 hours) at high risk of adverse glycaemia (insulin treatment prior to hospital; or BG &lt;4, &gt;15 or two BG &gt;10 mmol/L in the first 48 hours) were recruited. BG data from day 2 until discharge, along with demographic and clinical features, was collected. The primary outcome was the incidence of adverse glycaemic days (AGD) (rate per 1000 patient-days with any capillary BG measure &lt;4 or &gt;15 mmol/L). Overall, we observed 332 patients (1320patient-days and 4887 BG measurements). Compared to usual care, the incidence of AGD decreased from 405 to 320 per 1000 patient-days (21% decrease, p=0.002) which remained significant after MVA adjustment. During the intervention phase, there was decreased mean (±SD) patient-day BG (10.8 ±3.3 vs. 10.1 ±2.8, p&lt;0.001), decreased patient-days with hyperglycaemia (BG &gt;15 mmol/L) (10.4% vs. 6.1%, p=0.044) with no significant difference in patient-days with hypoglycaemia. Analysis of clinical outcomes is pending. An early intervention model of diabetes care decreased adverse glycaemia in cardiology in patients with diabetes.</description><subject>Blood glucose</subject><subject>Cardiology</subject><subject>Clinical outcomes</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Early intervention</subject><subject>Hyperglycemia</subject><subject>Hypoglycemia</subject><subject>Insulin</subject><subject>Patients</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1kN1LwzAUxYMoWKePvhd8jt58tGl80zndYKD4Ab6FNE1n5mxm0gn9702Zch8OF36ce89B6JzAJWVMXDU1kZgywfHT2-0ByohkEjMq3g9RBkAoJkKKY3QS4xoAyjQZWvzz1_lMh82Q3zld297GfNH1NvzYrne-y1sf8rlbfeBnFz_zqQ6N8xu_GhK11b1LVDxFR63eRHv2pxP0cj97nc7x8vFhMb1ZYlOWHBMpGDfAgRKQNRSyScLSVjbpO1trQQiYCipTWcF5Lagpi6JtSi5MpTmboIu96zb4752NvVr7XejSQUUpr5isuBgpvKdM8DEG26ptcF86DIqAGrtSY1dqzK5SdvYLPOJZzQ</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>FOURLANOS, SPIROS</creator><creator>MINGOS, NICHOLAS D.</creator><creator>ROWAN, LOIS M.</creator><creator>BARMANRAY, RAHUL</creator><creator>KYI, MERVYN</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20190601</creationdate><title>2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients</title><author>FOURLANOS, SPIROS ; MINGOS, NICHOLAS D. ; ROWAN, LOIS M. ; BARMANRAY, RAHUL ; KYI, MERVYN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c664-19734c0402109b059d09b30216d179eba7110c808c8e744b72c655fd647c8a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Blood glucose</topic><topic>Cardiology</topic><topic>Clinical outcomes</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Early intervention</topic><topic>Hyperglycemia</topic><topic>Hypoglycemia</topic><topic>Insulin</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FOURLANOS, SPIROS</creatorcontrib><creatorcontrib>MINGOS, NICHOLAS D.</creatorcontrib><creatorcontrib>ROWAN, LOIS M.</creatorcontrib><creatorcontrib>BARMANRAY, RAHUL</creatorcontrib><creatorcontrib>KYI, MERVYN</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FOURLANOS, SPIROS</au><au>MINGOS, NICHOLAS D.</au><au>ROWAN, LOIS M.</au><au>BARMANRAY, RAHUL</au><au>KYI, MERVYN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2019-06-01</date><risdate>2019</risdate><volume>68</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Adverse glycaemia in hospital is associated with worse clinical outcomes. Given the high prevalence of diabetes in the cardiology wards, we introduced an early intervention model of diabetes care in high-risk inpatients aiming to decrease adverse glycaemia. A prospective pre- and post-intervention study was conducted in a tertiary referral hospital cardiology ward. It consisted of an initial 6-month baseline phase of standard care (a ‘reactive’ referral-based diabetes consultation service), followed by an 9-month intervention phase, comprising a ‘proactive’ multidisciplinary inpatient diabetes team (IDT) assisted by networked blood glucose (BG) meter technology. The proactive IDT performed electronic surveillance of capillary BG measurements and provided an early consultation service (within 24 hours of admission), without waiting for referral from the parent team. Consecutive inpatients admitted to the cardiology ward (length of stay &gt;48 hours) at high risk of adverse glycaemia (insulin treatment prior to hospital; or BG &lt;4, &gt;15 or two BG &gt;10 mmol/L in the first 48 hours) were recruited. BG data from day 2 until discharge, along with demographic and clinical features, was collected. The primary outcome was the incidence of adverse glycaemic days (AGD) (rate per 1000 patient-days with any capillary BG measure &lt;4 or &gt;15 mmol/L). Overall, we observed 332 patients (1320patient-days and 4887 BG measurements). Compared to usual care, the incidence of AGD decreased from 405 to 320 per 1000 patient-days (21% decrease, p=0.002) which remained significant after MVA adjustment. During the intervention phase, there was decreased mean (±SD) patient-day BG (10.8 ±3.3 vs. 10.1 ±2.8, p&lt;0.001), decreased patient-days with hyperglycaemia (BG &gt;15 mmol/L) (10.4% vs. 6.1%, p=0.044) with no significant difference in patient-days with hypoglycaemia. Analysis of clinical outcomes is pending. An early intervention model of diabetes care decreased adverse glycaemia in cardiology in patients with diabetes.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db19-2374-PUB</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_journals_2248398474
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Blood glucose
Cardiology
Clinical outcomes
Diabetes
Diabetes mellitus
Early intervention
Hyperglycemia
Hypoglycemia
Insulin
Patients
title 2374-PUB: Early Diabetes Intervention for High-Risk Cardiology Inpatients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T02%3A03%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2374-PUB:%20Early%20Diabetes%20Intervention%20for%20High-Risk%20Cardiology%20Inpatients&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=FOURLANOS,%20SPIROS&rft.date=2019-06-01&rft.volume=68&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db19-2374-PUB&rft_dat=%3Cproquest_cross%3E2248398474%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2248398474&rft_id=info:pmid/&rfr_iscdi=true